Notice of Intent To Grant a Partially Exclusive Patent License; Oasis Diagnostics Corp, 61124 [E7-21202]

Download as PDF 61124 Federal Register / Vol. 72, No. 208 / Monday, October 29, 2007 / Notices Dated: October 23, 2007. L.M. Bynum Alternate OSD Federal Register Liaison Officer, DoD. [FR Doc. 07–5346 Filed 10–26–07; 8:45 am] BILLING CODE 5001–06–C DEPARTMENT OF DEFENSE Silver Spring, MD 20910–7500, telephone: 301–319–7428. (Authority: 35 U.S.C. 207, 37 CFR Part 404) Dated: October 23, 2007. T.M. Cruz, Lieutenant, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. E7–21202 Filed 10–26–07; 8:45 am] BILLING CODE 3810–FF–P Department of the Navy (Authority: 35 U.S.C. 207, 37 CFR Part 404) Dated: October 23, 2007. T.M. Cruz, Lieutenant, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. E7–21204 Filed 10–26–07; 8:45 am] BILLING CODE 3810–FF–P Notice of Intent To Grant a Partially Exclusive Patent License; Oasis Diagnostics Corp DEPARTMENT OF DEFENSE Department of the Navy, DoD. ACTION: Notice. Notice of Intent To Grant a Partially Exclusive Patent License; Oasis Diagnostics Corp 15:25 Oct 26, 2007 Jkt 214001 Department of the Navy, DoD. Notice. AGENCY: ACTION: SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to Oasis Diagnostics Corp., a revocable, nonassignable, partially exclusive license to practice worldwide the Government owned inventions described in U.S. Patent 6,927,068 entitled ‘‘A Rapid and Non-Invasive Method to Evaluate Immunization Status of a Patient’’ issued 9 August 2005 and related foreign filings (PCT/US 2003/002239, EP/1490665, and AU/ 2003301840) in the fields of detection of antibodies in present in oral fluids from the group saliva, oral rinse expectorant, oral mucosal transudate, gingival crevicular fluid, and phlegmuntil. DATES: Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than November 13, 2007. ADDRESSES: Written objections are to be filed with the Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910–7500. FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office of Technology Transfer, Naval Medical PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 Department of the Navy Notice of Intent To Grant a Partially Exclusive Patent License; United States—Vietnam Foundation Department of the Navy, DoD. Notice. AGENCY: ACTION: SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to United States-Vietnam Foundation, a revocable, nonassignable, partially exclusive license to practice worldwide the Government owned inventions described in the invention disclosed and claimed in International Application Number PCT/US2005/ 019963, with the International Filing Date of June 6, 2005, which was published on December 14, 2006 with the International Publication Number WO 2006/132635 A1, for ‘‘Hand-Held Fluorescence Polarimeter’’; and the national stage patent applications to be filed in Vietnam, Thailand, Cambodia, Laos, Indonesia, the Philippines and Myanmar in the fields of screening and diagnosis of: (1) Infectious diseases; (2) viral-induced cancer, such as Human Paplloma Virus/AIDs; and (3) toxins. DATES: Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than November 13, 2007. ADDRESSES: Written objections are to be filed with the Office of Technology E:\FR\FM\29OCN1.SGM 29OCN1 EN29OC07.008</GPH> SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to Oasis Diagnostics Corp., a revocable, nonassignable, partially exclusive license to practice worldwide the Government owned inventions described in U.S. Patent No. 6,841,159 issued on January 11, 2005, for ‘‘Rapid Lateral Flow Assay for Determining Exposure to Mycobacterium Tuberculosis and other mycobacteria’’; and related foreign filings (PCT/US 03/ 02311, EP/1478395, and AU/2003210662 filed) in the fields of detection of antibodies in present in oral fluids from the group saliva, oral rinse expectorant, oral mucosal transudate, gingival crevicular fluid, and phlegmuntil. DATES: Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than November 13, 2007. ADDRESSES: Written objections are to be filed with the Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910–7500. FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., VerDate Aug<31>2005 DEPARTMENT OF DEFENSE Department of the Navy AGENCY: rfrederick on PROD1PC67 with NOTICES Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910–7500, telephone: 301–319–7428.

Agencies

[Federal Register Volume 72, Number 208 (Monday, October 29, 2007)]
[Notices]
[Page 61124]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-21202]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent To Grant a Partially Exclusive Patent License; 
Oasis Diagnostics Corp

AGENCY: Department of the Navy, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to Oasis Diagnostics Corp., a revocable, nonassignable, 
partially exclusive license to practice worldwide the Government owned 
inventions described in U.S. Patent No. 6,841,159 issued on January 11, 
2005, for ``Rapid Lateral Flow Assay for Determining Exposure to 
Mycobacterium Tuberculosis and other mycobacteria''; and related 
foreign filings (PCT/US 03/02311, EP/1478395, and AU/2003210662 filed) 
in the fields of detection of antibodies in present in oral fluids from 
the group saliva, oral rinse expectorant, oral mucosal transudate, 
gingival crevicular fluid, and phlegmuntil.

DATES: Anyone wishing to object to the grant of this license must file 
written objections along with supporting evidence, if any, not later 
than November 13, 2007.

ADDRESSES: Written objections are to be filed with the Office of 
Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500, telephone: 301-319-7428.

(Authority: 35 U.S.C. 207, 37 CFR Part 404)

    Dated: October 23, 2007.
T.M. Cruz,
Lieutenant, Judge Advocate General's Corps, U.S. Navy, Federal Register 
Liaison Officer.
 [FR Doc. E7-21202 Filed 10-26-07; 8:45 am]
BILLING CODE 3810-FF-P